Scott L. Lundahl

Scott L. Lundahl discloses dealings in Dusa Pharmaceuticals Inc to SEC (Form 4). The record holds 30 filings, for trades running from 9 May 2008 to 20 December 2012.

The open-market side counts 2 purchases for €16k alongside 7 sales for €155k. On balance, insiders were net sellers of €139k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 16 share grants and 3 option exercises. Since January 2012: no purchases and 5 sales on the market.

The record was last updated on 20 December 2012 with a transaction (€369k) in Dusa Pharmaceuticals Inc. The most recent open-market purchase was published on 18 December 2009, 6,154 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.